The Fama-French Discovery
In 1992, Eugene Fama and Kenneth French published a landmark study in the Journal of Finance that fundamentally changed how academics and investors think about stock returns. They demonstrated that two factors, beyond the overall market, predicted returns:
- Size: Small stocks outperformed large stocks (~3-4% annually)
- Value: Cheap stocks (low price-to-book) outperformed expensive stocks (~4-5% annually)
When you combined these two - small AND cheap stocks - you got one of the most powerful single-factor tilts in all of finance: the small-cap value (SCV) premium, historically returning 4-8% annualized excess returns above the market.
This meant a simple strategy could beat the S&P 500: own the smallest, cheapest publicly traded stocks. The evidence was overwhelming.
The Historical Evidence: 1927-2023
Fama-French Data (1927-2023)
- Size premium: Small-cap stocks beat large-cap by ~3-4% annualized
- Value premium: Low P/B stocks beat high P/B by ~4.8% annualized
- Combined (SCV): Small-cap value beat the market by 4-8% annualized
- Persistence: The premium held across different time periods, countries, and methodologies
These returns are net of transaction costs but subject to data mining criticisms.
Over 96 years, the historical data was bulletproof. But then came 2010-2020.
The Lost Decade: 2010-2020
From 2010-2020, value investing (especially small-cap value) cratered. The Fama-French small-cap value factor lost money annually while the S&P 500, driven by mega-cap growth stocks (Apple, Amazon, Google, Microsoft), soared 400%+.
Investors abandoned value tilts. Vanguard Value funds underperformed Vanguard Growth funds by hundreds of basis points. Articles declared: "Value is dead. The factor doesn't work anymore." Factor investing blogs turned into graveyards.
The Narrative Crisis
From 2015-2020, the narrative flipped: "Why bother with small-cap value when mega-cap growth dominates? The Fama-French model is broken. Factor investing is dead."
But here's the thing: one lost decade doesn't invalidate 96 years of data.
Why Did Value Underperform? (2010-2020)
Several structural changes made growth outperform value during this period:
1. The Fed's Low-Rate Environment
After 2008, the Fed held rates at zero. In a zero-rate world, growth stocks (which compound earnings faster) were valued at higher multiples. Value stocks (which rely on dividends and near-term cash flows) became less attractive.
2. The Tech Concentration Play
The mega-cap tech giants had network effects (moats) that compound forever. Investors were paying high multiples for these moats. Value stocks were old-economy businesses (banks, industrials) facing structural headwinds.
3. Passive Index Growth
As passive investing grew, money flowed to the S&P 500 weighted by market cap. The largest stocks (mega-cap growth) got more capital, pushing them higher still. This created a virtuous cycle for mega-cap and a drag on value.
4. Crowding in Value
Many investors learned about the value premium and tilted toward it, driving valuations up for cheap stocks. This partly reflected the publication of the very research that showed the premium worked. Crowding breeds its own correction.
Recent Vindication: 2021-2024
Starting in 2021, the narrative flipped. Interest rates began rising. Growth stocks sold off. Value and small-cap began recovering.
- 2022: Value beat growth by 20+ percentage points
- 2023: Small-cap value rebounded strongly
- 2024-2025: Mixed, but value has shown resilience
This partial recovery is exactly what the factor premium theory predicts: factors go through long periods of underperformance and outperformance. The ones that persist are real. Those that disappear forever were statistical artifacts.
The Key Insight
A factor that underperforms for 10 years but then outperforms is real. A factor that underperforms forever is lucky data mining. The small-cap value premium shows the pattern of a real, fundamental factor.
The Behavioral Explanation: Why the Premium Persists
If the small-cap value premium is so obvious, why doesn't arbitrage eliminate it? Why do cheap, small stocks outperform?
Academic research points to behavioral reasons:
- Overconfidence in growth: Investors extrapolate the past too much. Small, cheap companies feel risky even though they may be underpriced.
- Neglect: Small stocks get less analyst coverage. Inefficiency persists due to lack of attention.
- Behavioral aversion: Investors prefer "story stocks" (Tesla) to boring small-cap value (Wolverine World Wide).
- Institutional constraints: Many funds have minimum market cap requirements, excluding small stocks artificially.
As long as psychology remains constant, the premium should persist. And psychology changes slowly.
The Dimensional Fund Advisors Perspective
Dimensional Fund Advisors (DFA), founded by Fama and built on the Fama-French factors, has continuously studied factor persistence. Their conclusion: the small-cap and value premiums are real, driven by fundamental economic risks, and likely to persist.
DFA's small-cap value strategies have underperformed for periods but outperformed over longer horizons, consistent with the premium thesis. The fact that DFA built a multi-billion-dollar firm on these factors suggests serious institutional confidence in their persistence.
Implementing a Small-Cap Value Tilt Today
Low-Cost SCV ETFs
- AVUV (Avantis US Small Cap Value ETF) – 0.25% expense ratio, high-quality small-cap value focus
- VBR (Vanguard Small-Cap Value ETF) – 0.08% expense ratio, large universe
- IJS (iShares S&P 500 Small-Cap Value ETF) – 0.25% expense ratio, S&P methodology
How to size the position: most researchers recommend 10-20% of your equity allocation to small-cap value. This gives you meaningful exposure to the premium without betting your portfolio on a single factor.
A simple example: $100,000 portfolio
- $70,000 in total US stock market (VTI)
- $15,000 in small-cap value tilt (AVUV or VBR)
- $15,000 in international and bonds
This overweights small-cap value relative to market weight (which is ~5%) while keeping it from being too concentrated.
The Patience Required
Factor Volatility
Small-cap value can underperform for 10 years. If you can't stomach that, don't tilt toward it. The premium only materializes if you have the discipline and capital to hold through drawdowns. A 10-year underperformance period is brutal.
But historically, patient investors have been rewarded. The question is: are you patient enough?
The Bottom Line
The small-cap value premium is real, documented, and persistent over 96+ years of data. The 2010-2020 underperformance was painful, but it's exactly the pattern you'd expect from a real fundamental factor - not a permanent disappearance.
If you believe in the Fama-French framework and can tolerate long stretches of underperformance, a 10-20% tilt toward small-cap value can boost long-term returns by 1-2% annualized. For a 30-year horizon, that compounds to substantial wealth.
The challenge isn't the math. It's the patience.
Related Articles & Tools
Momentum Factor Investing
Why momentum - recent winners keep winning - is one of the most robust factors.
Read ArticleQuality Factor Investing
Find companies with economic moats and durable competitive advantages.
Read ArticleMargin of Safety
Benjamin Graham's principle of buying with a discount to intrinsic value.
Read ArticleFree Tools & Courses
Portfolio vs S&P 500
Backtest a small-cap value tilt (VBR, IJS) against a pure SPY portfolio.
Open Tool →Dividend & Value Stock Screener
Filter stocks by low P/E and small market cap to find value candidates.
Open Tool →Index Fund Fundamentals
Learn how to incorporate factor tilts into a core index fund portfolio.
Start Free →